We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleFeasibility and pharmacokinetic study of a chimeric anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) in relapsed B-cell lymphoma.AuthorsTobinai, K.; Kobayashi, Y.; Narabayashi, M.; Ogura, M.; Kagami, Y.; Morishima, Y.; Ohtsu, T.; Igarashi, T.; Sasaki, Y.; Kinoshita, T.; Murate, T.PublicationAnnals of Oncology, 1998, Vol 9, Issue 5, p527ISSN0923-7534Publication typearticle